Sgouros G - Search Results

1

Rationales, evidence, and design considerations for fractionated radioimmunotherapy.

DeNardo GL, Schlom J, Buchsbaum DJ, Meredith RF, O'Donoghue JA, Sgouros G, Humm JL, DeNardo SJ. DeNardo GL, et al. Among authors: sgouros g. Cancer. 2002 Feb 15;94(4 Suppl):1332-48. doi: 10.1002/cncr.10304. Cancer. 2002. PMID: 11877764 Free article.

2

General solution of the radioactive parent-daughter relationship.

Lief EP, Sgouros G, Humm JL. Lief EP, et al. Among authors: sgouros g. Med Phys. 1994 Nov;21(11):1739-40. doi: 10.1118/1.597274. Med Phys. 1994. PMID: 7891635 No abstract available.

3

Immunoadsorption: an enhancement strategy for radioimmunotherapy.

DeNardo GL, Maddock SW, Sgouros G, Scheibe PO, DeNardo SJ. DeNardo GL, et al. Among authors: sgouros g. J Nucl Med. 1993 Jun;34(6):1020-7. J Nucl Med. 1993. PMID: 8509840 Free article. No abstract available.

4

Current status of radioimmunotherapy.

Larson SM, Divgi CR, Scott A, Sgouros G, Graham MC, Kostakoglu L, Scheinberg D, Cheung NK, Schlom J, Finn RD. Larson SM, et al. Among authors: sgouros g. Nucl Med Biol. 1994 Jul;21(5):785-92. doi: 10.1016/0969-8051(94)90050-7. Nucl Med Biol. 1994. PMID: 9241655

5

Single chain antigen binding protein (sFv CC49): first human studies in colorectal carcinoma metastatic to liver.

Larson SM, El-Shirbiny AM, Divgi CR, Sgouros G, Finn RD, Tschmelitsch J, Picon A, Whitlow M, Schlom J, Zhang J, Cohen AM. Larson SM, et al. Among authors: sgouros g. Cancer. 1997 Dec 15;80(12 Suppl):2458-68. doi: 10.1002/(sici)1097-0142(19971215)80:12+<2458::aid-cncr17>3.3.co;2-t. Cancer. 1997. PMID: 9406696

6

Overcoming the nephrotoxicity of radiometal-labeled immunoconjugates: improved cancer therapy administered to a nude mouse model in relation to the internal radiation dosimetry.

Behr TM, Sharkey RM, Sgouros G, Blumenthal RD, Dunn RM, Kolbert K, Griffiths GL, Siegel JA, Becker WS, Goldenberg DM. Behr TM, et al. Among authors: sgouros g. Cancer. 1997 Dec 15;80(12 Suppl):2591-610. doi: 10.1002/(sici)1097-0142(19971215)80:12+<2591::aid-cncr35>3.3.co;2-a. Cancer. 1997. PMID: 9406714

7

Pharmacokinetic model of iodine-131-G250 antibody in renal cell carcinoma patients.

Loh A, Sgouros G, O'Donoghue JA, Deland D, Puri D, Capitelli P, Humm JL, Larson SM, Old LJ, Divgi CR. Loh A, et al. Among authors: sgouros g. J Nucl Med. 1998 Mar;39(3):484-9. J Nucl Med. 1998. PMID: 9529296 Free article. Clinical Trial.

8

Interferon-gamma and monoclonal antibody 131I-labeled CC49: outcomes in patients with androgen-independent prostate cancer.

Slovin SF, Scher HI, Divgi CR, Reuter V, Sgouros G, Moore M, Weingard K, Pettengall R, Imbriaco M, El-Shirbiny A, Finn R, Bronstein J, Brett C, Milenic D, Dnistrian A, Shapiro L, Schlom J, Larson SM. Slovin SF, et al. Among authors: sgouros g. Clin Cancer Res. 1998 Mar;4(3):643-51. Clin Cancer Res. 1998. PMID: 9533532

9

Mathematical model of 5-[125I]iodo-2'-deoxyuridine treatment: continuous infusion regimens for hepatic metastases.

Sgouros G, O'Donoghue JA, Larson SM, Macapinlac H, Larson JJ, Kemeny N. Sgouros G, et al. Int J Radiat Oncol Biol Phys. 1998 Jul 15;41(5):1177-83. doi: 10.1016/s0360-3016(98)00175-8. Int J Radiat Oncol Biol Phys. 1998. PMID: 9719130

10

Radioimmunotherapy with alpha-emitting nuclides.

McDevitt MR, Sgouros G, Finn RD, Humm JL, Jurcic JG, Larson SM, Scheinberg DA. McDevitt MR, et al. Among authors: sgouros g. Eur J Nucl Med. 1998 Sep;25(9):1341-51. doi: 10.1007/s002590050306. Eur J Nucl Med. 1998. PMID: 9724387 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

262 results

Search Page

Filters